FOLFOXIRI plus bevacizumab as conversion-therapy for liver metastases in colorectal cancer: A necessity?
Saved in:
| Title: | FOLFOXIRI plus bevacizumab as conversion-therapy for liver metastases in colorectal cancer: A necessity? |
|---|---|
| Authors: | Modest, D.P.1,2,3,4 dominik.modest@med.uni-muenchen.de, Neumann, U.P.1,2,3,4, Pratschke, J.1,2,3,4 |
| Source: | European Journal of Cancer. Mar2017, Vol. 73, p71-73. 3p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09598049 |
|---|---|
| DOI: | 10.1016/j.ejca.2016.12.005 |
